Results 281 to 290 of about 700,247 (353)

Interaction of ferroptosis and cuproptosis in the perspective of pulmonary hypertension. [PDF]

Front Cardiovasc Med
Yang Y, Liang L, Pei W, Sun Y.
europepmc   +1 more source

Studies on Roentgenologic Appearance in Pulmonary Hypertension : Relationship between the Appearance of Pulmonary Vasculature on the Roenrgenologic Chest Film and Pulmonary Hemodynamics

, 1962
Eiichi Miyake
openalex   +2 more sources

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Transcriptome analysis identifies upregulation of <i>GBP4</i> in sarcoidosis and pulmonary hypertension. [PDF]

Chin Med J Pulm Crit Care Med
Hu S, Jiang J, Wang J, Li Q, Wu W, Xu JF.   +5 more
europepmc   +1 more source

Signaling pathways and targeted therapy for pulmonary hypertension. [PDF]

Signal Transduct Target Ther
Adu-Amankwaah J, Shi Y, Song H, Ma Y, Liu J, Wang H, Yuan J, Sun K, Hu Q, Tan R.   +9 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Patient experience with pulmonary hypertension in Spain. [PDF]

Orphanet J Rare Dis
Mira JJ, Torres DG, Santiñá M.
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Increased contractility affects left ventricular kinetic energy in pulmonary hypertension. [PDF]

Physiol Rep
Bergström E, Pola K, Kjellström B, Töger J, Arvidsson PM, Carlsson M, Rådegran G, Arheden H, Ostenfeld E.   +8 more
europepmc   +1 more source